[TDZ, a local hemostatic, for dental use: clinical studies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000535:Aluminum / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002594:Cetylpyridinium / Q000494:pharmacology / Q000627:therapeutic use*; D012534:Dental Scaling; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D005881:Gingiva / Q000187:drug effects*; D005893:Gingivoplasty; D006490:Hemostatics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D051381:Rats
D004338:Drug Combinations; D006490:Hemostatics; D011726:Pyridinium Compounds; C026316:TDZ (hemostatic); D008012:Lidocaine; D000535:Aluminum; D002594:Cetylpyridinium